News and stories
Careers
Events
Contact us
Donate
한국어
Who We Are
Vision & Mission
Why Vaccines
IVI in Brief
History
Director General’s Message
Policies
Gender equality
Environmental sustainability
Leadership
Board of Trustees
Scientific Advisory Group
Executive Leadership Team
Senior Management
Our Partners
FAQ
What We Do
Overview
Discover
Develop
Deliver
Build Capacity
Disease Areas
Cholera
Typhoid
Dengue
MERS
Schistosomiasis
Chikungunya
COVID-19
AMR
RADAAR
Other
Where We Work
Overview Map
IVI Member States
Collaborating Centers
IVI Collaborating Centers
UoA, Madagascar
KNUST, Ghana
AHRI, Ethiopia
Our Impact
Journal Publications
International Vaccinology Course
News and stories
Annual Report & Financial Statement
✕
ACCELERATING VACCINES
FOR GLOBAL HEALTH
IVI at work on
COVID-19
Learn more
Vaccines
Save Lives
Read more
Watch video
Accelerating Vaccines Critical
to Global Health
OVERVIEW of our work
International Organization
for
Vaccine R&D
and Delivery
Headquarters in Seoul, Korea
Read More
Help Us Make
Vaccines a Reality for All
Donate
IVI is uniquely present at every step of the vaccine value chain
Discover
Develop
Deliver
Build Capacity
IVI News & Announcements
SK bioscience’s COVID-19 vaccine approved for use by Republic of Korea
IVI goes to Sweden
Spain joins IVI with flag-raising ceremony
The IVI Blog
SK bioscience’s COVID-19 vaccine approved for use by Republic of Korea
IVI to operate training courses for WHO global biomanufacturing training hub in Republic of Korea
Reflecting on 25 years of IVI with Dr. Richard Mahoney
Global Partners
Subscribe to our mailing list
새소식 구독하기
Leave this field empty if you're human:
ACCELERATING VACCINES
FOR GLOBAL HEALTH
IVI at work on
COVID-19
Learn more
Vaccines
Save
Lives
Read more
Watch video
Accelerating
Vaccines
Critical to
Global Health
OVERVIEW of our work
International
Organization
for Vaccine R&D
and Delivery
Headquarters in Seoul, Korea
Read More
Vaccines
Save
Lives
DONATE
IVI is uniquely present at every step of the vaccine value chain
Discover
Develop
Deliver
Build Capacity
IVI News &
Announcements
SK bioscience’s COVID-19 vaccine approved for use by Republic of Korea
IVI goes to Sweden
Spain joins IVI with flag-raising ceremony
The IVI Blog
SK bioscience’s COVID-19 vaccine approved for use by Republic of Korea
IVI to operate training courses for WHO global biomanufacturing training hub in Republic of Korea
Reflecting on 25 years of IVI with Dr. Richard Mahoney
Global Partners
Subscribe to our mailing list
새소식 구독하기
Leave this field empty if you're human:
News and stories
Careers
Events
Contact us
Donate
한국어
X
